Periodic Report
KM Pharmaceutical sold KRW 4.0 billion in Q3 and lost KRW 0.5 billion from its main business; sales fell 8.0% from a year earlier.
225430 · KOSDAQ · Based on DART filings
2 total · 20 per page
KM Pharmaceutical sold KRW 4.0 billion in Q3 and lost KRW 0.5 billion from its main business; sales fell 8.0% from a year earlier.
· Report on Large Shareholdings
Kang Il Mo and related parties kept their 49.66% stake in KMPHARMACEUTICAL Co.,Ltd. and fully repaid one share-backed loan. Pledged shares fell from 1,194,503 to 1,100,000; the remaining loan is due 2026.12.04.
Get app alerts for new disclosures from KMPHARMACEUTICAL Co.,Ltd..